Ares Capital Corporation (ARCC)
Official siteFINANCIAL SERVICES • ASSET MANAGEMENT • NASDAQ
Market Cap: $13.84B
Last updated: Nov 17, 2026 at 11:04 AM ET
Ares Capital Corporation (ARCC) Stock Forecast
Analysts expect Ares Capital (ARCC) to earn $1.88 per share in the fiscal year ending Dec 31, 2026, on revenue of $3.08B. Of 14 analysts, 11 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 11 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 14 ratings average 1.93, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 79% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 4 | 28.6% |
| Buy | 7 | 50.0% |
| Hold | 3 | 21.4% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 14
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 3.2% and revenue estimates rise 6.8%.
- Fiscal year ending Dec 31, 2026
- $1.88
- EPS consensus, revenue $3.08B
- Fiscal year ending Dec 31, 2027
- $1.94
- EPS consensus, revenue $3.29B
- Next report
- Feb 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.88 | $1.85 to $1.98 | 13 | $3.08B | $3.06B to $3.10B | 10 |
| Dec 31, 2027 | $1.94 | $1.89 to $2.02 | 13 | $3.29B | $3.07B to $3.54B | 10 |
Quarterly Estimates
The EPS consensus falls from $0.49 for the quarter ending Dec 31, 2026 to $0.48 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.49 | $0.45 to $0.55 | 15 | $798.61M | $747.74M to $850.50M | 11 |
| Mar 31, 2027 | $0.48 | $0.46 to $0.50 | 12 | $791.43M | $764.00M to $823.00M | 10 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 10 upward and 16 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 11 |
| Fiscal year ending Dec 31, 2027 | 8 | 2 |
| Quarter ending Mar 31, 2027 | 2 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 1.6% from $1.91.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $1.88 | $1.91 | $1.91 | $1.91 | $1.91 | -1.4% |
| Fiscal year ending Dec 31, 2027 | $1.94 | $1.94 | $1.93 | $1.93 | $1.93 | +0.5% |
| Quarter ending Mar 31, 2027 | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | -0.9% |
Frequently Asked Questions About ARCC
What is the ARCC stock forecast?
Consensus analyst estimates put Ares Capital's EPS at $1.88 for the fiscal year ending Dec 31, 2026, on revenue of $3.08B. The consensus rating from 14 analysts is Buy.
How do analysts rate ARCC stock?
Of 14 analysts covering Ares Capital, 4 rate it Strong Buy, 7 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ARCC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.88, with estimates from $1.85 to $1.98 from 13 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.94, with estimates from $1.89 to $2.02 from 13 analysts.
What revenue do analysts expect from Ares Capital next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $3.08B, with estimates from $3.06B to $3.10B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.29B, with estimates from $3.07B to $3.54B.
How many analysts cover ARCC?
14 analysts rate Ares Capital stock, and 13 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ARCC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors